The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-04
DOI
10.1111/bju.14987
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
- (2018) Jenny L. Donovan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Danger of Applying the ProtecT Trial to Minority Populations
- (2018) Shearwood McClelland et al. JAMA Oncology
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee
- (2016) Emma L Turner et al. BRITISH JOURNAL OF CANCER
- Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
- (2016) Jenny L. Donovan et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should Gleason 6 be labeled as cancer?
- (2015) Ibrahim Kulac et al. CURRENT OPINION IN UROLOGY
- Gleason drift in the NIHR ProtecT study
- (2015) Jon Oxley et al. HISTOPATHOLOGY
- Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer
- (2015) Jeffrey J. Tosoian et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort
- (2014) Ghassan A. Barayan et al. BJU INTERNATIONAL
- Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
- (2014) J Athene Lane et al. LANCET ONCOLOGY
- Tracking the clonal origin of lethal prostate cancer
- (2013) Michael C. Haffner et al. JOURNAL OF CLINICAL INVESTIGATION
- Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?
- (2012) Hillary M. Ross et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Pre-treatment risk stratification of prostate cancer patients: A critical review
- (2012) George Rodrigues et al. CUAJ-Canadian Urological Association Journal
- Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study
- (2011) J W F Catto et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started